Select Medical (SEM) Stock Forecast, Price Target & Predictions
SEM Stock Forecast
Select Medical stock forecast is as follows: an average price target of $40.00 (represents a 9.56% upside from SEM’s last price of $36.51) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
SEM Price Target
The average price target for Select Medical (SEM) is $40.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $40.00 to $40.00. This represents a potential 9.56% upside from SEM's last price of $36.51.
SEM Analyst Ratings
According to 2 Wall Street analysts, Select Medical's rating consensus is 'Buy'. The analyst rating breakdown for SEM stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Select Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Frank Morgan | RBC Capital | $40.00 | $31.43 | 27.27% | 9.56% |
The latest Select Medical stock forecast, released on May 06, 2024 by Frank Morgan from RBC Capital, set a price target of $40.00, which represents a 27.27% increase from the stock price at the time of the forecast ($31.43), and a 9.56% increase from SEM last price ($36.51).
Select Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $40.00 |
| Last Closing Price | $36.51 | $36.51 | $36.51 |
| Upside/Downside | -100.00% | -100.00% | 9.56% |
In the current month, the average price target of Select Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Select Medical's last price of $36.51. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 20, 2024 | Benchmark | Buy | Buy | Hold |
| Aug 20, 2024 | Benchmark Co. | Underperform | Underperform | Hold |
| Jul 16, 2024 | Benchmark | Underperform | Underperform | Hold |
| Jul 16, 2024 | RBC Capital | Buy | Buy | Hold |
| Jul 16, 2024 | Benchmark | Buy | Buy | Hold |
| May 06, 2024 | Benchmark | Buy | Buy | Hold |
| May 06, 2024 | RBC Capital | Outperform | Outperform | Hold |
Select Medical's last stock rating was published by Benchmark on Aug 20, 2024. The company gave SEM a "Buy" rating, the same as its previous rate.
Select Medical Financial Forecast
Select Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.67B | $1.67B | $1.66B | $1.58B | $1.57B | $1.58B | $1.60B | $1.56B | $1.53B | $1.56B | $1.55B | $1.46B | $1.42B | $1.23B | $1.41B | $1.37B | $1.39B |
| Avg Forecast | $1.95B | $1.95B | $1.96B | $1.97B | $1.83B | $1.83B | $1.84B | $1.86B | $1.75B | $1.74B | $1.74B | $1.74B | $1.64B | $1.63B | $1.65B | $1.65B | $1.58B | $1.56B | $1.58B | $1.56B | $1.52B | $1.44B | $1.44B | $1.44B | $1.41B | $1.37B | $1.15B | $1.36B | $1.34B | $1.31B |
| High Forecast | $1.96B | $1.96B | $1.97B | $1.99B | $1.84B | $1.84B | $1.85B | $1.88B | $1.77B | $1.74B | $1.74B | $1.74B | $1.65B | $1.65B | $1.66B | $1.66B | $1.59B | $1.56B | $1.58B | $1.56B | $1.52B | $1.44B | $1.44B | $1.44B | $1.41B | $1.37B | $1.15B | $1.36B | $1.34B | $1.31B |
| Low Forecast | $1.94B | $1.94B | $1.95B | $1.97B | $1.82B | $1.82B | $1.83B | $1.86B | $1.74B | $1.73B | $1.74B | $1.74B | $1.63B | $1.59B | $1.64B | $1.64B | $1.58B | $1.56B | $1.58B | $1.56B | $1.52B | $1.44B | $1.44B | $1.44B | $1.41B | $1.37B | $1.15B | $1.36B | $1.34B | $1.31B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.02% | 1.01% | 1.00% | 1.01% | 1.00% | 1.02% | 1.02% | 1.06% | 1.09% | 1.07% | 1.04% | 1.04% | 1.07% | 1.04% | 1.03% | 1.06% |
Select Medical's average Quarter revenue forecast for Dec 23 based on 2 analysts is $1.64B, with a low forecast of $1.63B, and a high forecast of $1.65B. SEM's average Quarter revenue forecast represents a -1.60% decrease compared to the company's last Quarter revenue of $1.67B (Sep 23).
Select Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.46B | $219.64M | $212.44M | $145.87M | $151.01M | $178.22M | $160.42M | $141.33M | $188.55M | $315.42M | $239.63M | $199.37M | $192.64M | $164.62M | $172.90M | $140.11M | $150.86M |
| Avg Forecast | $254.00M | $253.78M | $255.63M | $257.44M | $238.39M | $238.84M | $240.07M | $243.08M | $228.08M | $226.46M | $227.48M | $209.15M | $213.73M | $212.12M | $214.50M | $190.13M | $112.69M | $203.31M | $206.30M | $172.85M | $198.44M | $188.19M | $187.25M | $157.14M | $183.99M | $178.19M | $150.57M | $145.88M | $174.14M | $171.24M |
| High Forecast | $255.68M | $255.45M | $257.32M | $259.14M | $239.96M | $240.41M | $241.65M | $244.68M | $230.68M | $226.73M | $227.48M | $250.98M | $215.14M | $215.24M | $215.92M | $228.16M | $135.23M | $203.31M | $206.30M | $207.42M | $198.44M | $188.19M | $187.25M | $188.56M | $183.99M | $178.19M | $150.57M | $175.06M | $174.14M | $171.24M |
| Low Forecast | $252.94M | $252.72M | $254.56M | $256.36M | $237.39M | $237.84M | $239.06M | $242.06M | $226.77M | $226.18M | $227.48M | $167.32M | $212.84M | $207.69M | $213.61M | $152.11M | $90.15M | $203.31M | $206.30M | $138.28M | $198.44M | $188.19M | $187.25M | $125.71M | $183.99M | $178.19M | $150.57M | $116.70M | $174.14M | $171.24M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.86% | 1.02% | 1.12% | 1.29% | 0.74% | 0.86% | 0.93% | 0.71% | 1.00% | 1.68% | 1.53% | 1.08% | 1.08% | 1.09% | 1.19% | 0.80% | 0.88% |
2 analysts predict SEM's average Quarter EBITDA for Dec 23 to be $213.73M, with a high of $215.14M and a low of $212.84M. This is -85.32% lower than Select Medical's previous annual EBITDA (Sep 23) of $1.46B.
Select Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $48.18M | $78.24M | $70.81M | $37.71M | $38.13M | $55.21M | $49.12M | $66.31M | $76.93M | $164.89M | $110.55M | $77.27M | $76.95M | $51.65M | $53.13M | $32.07M | $30.73M |
| Avg Forecast | $60.30M | $62.23M | $81.66M | $67.77M | $47.78M | $56.53M | $70.21M | $75.63M | $36.72M | $51.48M | $75.00M | $96.48M | $42.55M | $50.39M | $66.82M | $87.71M | $44.23M | $55.80M | $68.32M | $79.74M | $37.83M | $64.80M | $69.16M | $72.49M | $44.38M | $36.19M | $2.18M | $44.82M | $23.12M | $25.80M |
| High Forecast | $60.81M | $62.77M | $82.36M | $68.36M | $48.19M | $57.01M | $70.81M | $76.85M | $37.94M | $51.92M | $75.01M | $115.78M | $45.30M | $52.85M | $67.39M | $105.25M | $53.07M | $55.80M | $68.32M | $95.69M | $37.83M | $64.80M | $69.16M | $86.99M | $44.38M | $36.19M | $2.18M | $53.79M | $23.12M | $25.80M |
| Low Forecast | $59.97M | $61.89M | $81.21M | $67.41M | $47.52M | $56.22M | $69.83M | $75.22M | $36.52M | $51.20M | $75.00M | $77.19M | $39.81M | $46.71M | $66.46M | $70.17M | $35.38M | $55.80M | $68.32M | $63.79M | $37.83M | $64.80M | $69.16M | $57.99M | $44.38M | $36.19M | $2.18M | $35.86M | $23.12M | $25.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 1.17% | 0.81% | 0.85% | 0.68% | 0.81% | 0.62% | 1.75% | 1.19% | 2.38% | 1.53% | 1.74% | 2.13% | 23.66% | 1.19% | 1.39% | 1.19% |
Select Medical's average Quarter net income forecast for Dec 23 is $42.55M, with a range of $39.81M to $45.30M. SEM's average Quarter net income forecast represents a -11.68% decrease compared to the company's last Quarter net income of $48.18M (Sep 23).
Select Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $41.32M | $42.51M | $42.28M | $38.76M | $39.49M | $37.27M | $37.51M | $37.95M | $37.88M | $35.74M | $35.40M | $35.23M | $35.52M | $33.46M | $33.83M | $34.06M | $34.38M |
| Avg Forecast | $47.49M | $47.45M | $47.80M | $48.13M | $44.57M | $44.65M | $44.88M | $45.45M | $42.64M | $42.34M | $42.53M | $44.51M | $39.96M | $39.66M | $40.10M | $40.47M | $33.67M | $38.01M | $38.57M | $36.79M | $37.10M | $35.18M | $35.01M | $33.44M | $34.40M | $33.32M | $28.15M | $28.54M | $32.56M | $32.02M |
| High Forecast | $47.80M | $47.76M | $48.11M | $48.45M | $44.86M | $44.95M | $45.18M | $45.75M | $43.13M | $42.39M | $42.53M | $53.42M | $40.22M | $40.24M | $40.37M | $48.56M | $40.40M | $38.01M | $38.57M | $44.15M | $37.10M | $35.18M | $35.01M | $40.13M | $34.40M | $33.32M | $28.15M | $34.25M | $32.56M | $32.02M |
| Low Forecast | $47.29M | $47.25M | $47.60M | $47.93M | $44.38M | $44.47M | $44.70M | $45.26M | $42.40M | $42.29M | $42.53M | $35.61M | $39.79M | $38.83M | $39.94M | $32.37M | $26.93M | $38.01M | $38.57M | $29.43M | $37.10M | $35.18M | $35.01M | $26.76M | $34.40M | $33.32M | $28.15M | $22.84M | $32.56M | $32.02M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.06% | 1.04% | 1.15% | 1.04% | 0.97% | 1.02% | 1.02% | 1.08% | 1.02% | 1.06% | 1.02% | 1.07% | 1.19% | 1.19% | 1.05% | 1.07% |
Select Medical's average Quarter SG&A projection for Dec 23 is $39.96M, based on 2 Wall Street analysts, with a range of $39.79M to $40.22M. The forecast indicates a -3.28% fall compared to SEM last annual SG&A of $41.32M (Sep 23).
Select Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.38 | $0.61 | $0.70 | $0.25 | $0.31 | $0.43 | $0.37 | $0.51 | $0.59 | $1.26 | $0.85 | $0.59 | $0.80 | $0.40 | $0.41 | $0.33 | $0.34 |
| Avg Forecast | $0.49 | $0.50 | $0.66 | $0.55 | $0.39 | $0.46 | $0.57 | $0.61 | $0.30 | $0.42 | $0.61 | $0.57 | $0.34 | $0.41 | $0.54 | $0.42 | $0.36 | $0.45 | $0.55 | $0.28 | $0.31 | $0.52 | $0.56 | $0.61 | $0.36 | $0.29 | $0.02 | $0.32 | $0.19 | $0.21 |
| High Forecast | $0.49 | $0.51 | $0.66 | $0.55 | $0.39 | $0.46 | $0.57 | $0.62 | $0.31 | $0.42 | $0.61 | $0.57 | $0.37 | $0.43 | $0.54 | $0.42 | $0.36 | $0.45 | $0.55 | $0.28 | $0.31 | $0.52 | $0.56 | $0.61 | $0.36 | $0.29 | $0.02 | $0.32 | $0.19 | $0.21 |
| Low Forecast | $0.48 | $0.50 | $0.66 | $0.54 | $0.38 | $0.45 | $0.56 | $0.61 | $0.29 | $0.41 | $0.61 | $0.57 | $0.32 | $0.38 | $0.54 | $0.42 | $0.36 | $0.45 | $0.55 | $0.28 | $0.31 | $0.52 | $0.56 | $0.61 | $0.36 | $0.29 | $0.02 | $0.32 | $0.19 | $0.21 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | 1.13% | 1.67% | 0.69% | 0.69% | 0.78% | 1.34% | 1.67% | 1.13% | 2.26% | 1.40% | 1.65% | 2.74% | 22.71% | 1.30% | 1.77% | 1.63% |
According to 2 Wall Street analysts, Select Medical's projected average Quarter EPS for Dec 23 is $0.34, with a low estimate of $0.32 and a high estimate of $0.37. This represents a -9.65% decrease compared to SEM previous annual EPS of $0.38 (Sep 23).
Select Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company | $42.33 | $82.33 | 94.50% | Buy |
| EHAB | Enhabit | $7.63 | $10.25 | 34.34% | Hold |
| MD | Pediatrix Medical Group | $15.14 | $18.17 | 20.01% | Hold |
| INNV | InnovAge | $5.90 | $6.80 | 15.25% | Hold |
| SEM | Select Medical | $36.51 | $40.00 | 9.56% | Buy |
| PNTG | Pennant Group | $32.38 | $34.67 | 7.07% | Buy |
| ADUS | Addus HomeCare | $128.96 | $129.40 | 0.34% | Buy |
| EHC | Encompass Health | $100.23 | $97.00 | -3.22% | Buy |
| ENSG | Ensign Group | $153.39 | $148.20 | -3.38% | Buy |
SEM Forecast FAQ
Is Select Medical a good buy?
Yes, according to 2 Wall Street analysts, Select Medical (SEM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of SEM's total ratings.
What is SEM's price target?
Select Medical (SEM) average price target is $40 with a range of $40 to $40, implying a 9.56% from its last price of $36.51. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Select Medical stock go up soon?
According to Wall Street analysts' prediction for SEM stock, the company can go up by 9.56% (from the last price of $36.51 to the average price target of $40), up by 9.56% based on the highest stock price target, and up by 9.56% based on the lowest stock price target.
Can Select Medical stock reach $50?
SEM's average twelve months analyst stock price target of $40 does not support the claim that Select Medical can reach $50 in the near future.
What are Select Medical's analysts' financial forecasts?
Select Medical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $7.37B (high $7.41B, low $7.33B), average EBITDA is $960.37M (high $966.71M, low $956.35M), average net income is $250.15M (high $252.87M, low $248.79M), average SG&A $179.56M (high $180.74M, low $178.81M), and average EPS is $2.02 (high $2.04, low $2.01). SEM's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $7.83B (high $7.88B, low $7.8B), average EBITDA is $1.02B (high $1.03B, low $1.02B), average net income is $271.96M (high $274.29M, low $270.48M), average SG&A $190.87M (high $192.12M, low $190.07M), and average EPS is $2.19 (high $2.21, low $2.18).
Did the SEM's actual financial results beat the analysts' financial forecasts?
Based on Select Medical's last annual report (Dec 2022), the company's revenue was $6.33B, beating the average analysts forecast of $6.29B by 0.74%. Apple's EBITDA was $635.52M, missing the average prediction of $695.14M by -8.58%. The company's net income was $158.99M, missing the average estimation of $248.08M by -35.91%. Apple's SG&A was $153.04M, beating the average forecast of $147.04M by 4.08%. Lastly, the company's EPS was $1.23, missing the average prediction of $1.64 by -24.87%. In terms of the last quarterly report (Sep 2023), Select Medical's revenue was $1.67B, beating the average analysts' forecast of $1.63B by 2.40%. The company's EBITDA was $1.46B, beating the average prediction of $212.12M by 586.49%. Select Medical's net income was $48.18M, missing the average estimation of $50.39M by -4.39%. The company's SG&A was $41.32M, beating the average forecast of $39.66M by 4.18%. Lastly, the company's EPS was $0.38, missing the average prediction of $0.407 by -6.54%